Your browser doesn't support javascript.
loading
Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
Blokker, Britt A; Maijo, Monica; Echeandia, Marta; Galduroz, Mikel; Patterson, Angela M; Ten, Anna; Philo, Mark; Schungel, Rebecca; Gutierrez-de Juan, Virginia; Halilbasic, Emina; Fuchs, Claudia; Le Gall, Gwenaelle; Milkiewicz, Malgorzata; Milkiewicz, Piotr; Banales, Jesus M; Rushbrook, Simon M; Mato, José M; Trauner, Michael; Müller, Michael; Martínez-Chantar, María Luz; Varela-Rey, Marta; Beraza, Naiara.
Affiliation
  • Blokker BA; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Maijo M; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Echeandia M; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Galduroz M; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Patterson AM; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Ten A; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Philo M; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Schungel R; Metabolomics Unit, Quadram Institute, Norwich, United Kingdom.
  • Gutierrez-de Juan V; Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, United Kingdom.
  • Halilbasic E; Department of Food, Nutrition, Facilities, University of Applied Sciences Münster, Münster, Germany.
  • Fuchs C; CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Derio, Spain.
  • Le Gall G; Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University Vienna, Vienna, Austria.
  • Milkiewicz M; Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University Vienna, Vienna, Austria.
  • Milkiewicz P; Metabolomics Unit, Quadram Institute, Norwich, United Kingdom.
  • Banales JM; Department of Medical Biology, Pomeranian Medical University, Szczecin, Poland.
  • Rushbrook SM; Liver and Internal Medicine Unit, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
  • Mato JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), CIBERehd, Ikerbasque, Donostia, Spain.
  • Trauner M; Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, United Kingdom.
  • Müller M; CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Derio, Spain.
  • Martínez-Chantar ML; Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University Vienna, Vienna, Austria.
  • Varela-Rey M; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Beraza N; CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Derio, Spain.
Hepatology ; 69(2): 699-716, 2019 02.
Article in En | MEDLINE | ID: mdl-30229970

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholestasis / Sirtuin 1 Type of study: Observational_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Hepatology Year: 2019 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholestasis / Sirtuin 1 Type of study: Observational_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Hepatology Year: 2019 Type: Article Affiliation country: United kingdom